VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 732 filers reported holding VANECK VECTORS ETF TR in Q1 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,084,333 | -11.5% | 40,295 | -0.9% | 0.05% | -8.5% |
| Q2 2023 | $1,224,634 | -8.1% | 40,672 | -1.2% | 0.06% | -28.0% |
| Q1 2023 | $1,332,270 | +26.4% | 41,183 | +12.0% | 0.08% | +9.3% |
| Q4 2022 | $1,054,211 | +16.2% | 36,783 | -2.2% | 0.08% | 0.0% |
| Q3 2022 | $907,000 | -15.9% | 37,608 | -4.4% | 0.08% | -16.7% |
| Q2 2022 | $1,078,000 | -54.1% | 39,356 | -35.7% | 0.09% | -46.1% |
| Q1 2022 | $2,348,000 | +256.8% | 61,225 | +199.0% | 0.17% | +240.8% |
| Q4 2021 | $658,000 | +8.9% | 20,476 | -0.2% | 0.05% | -41.0% |
| Q3 2021 | $604,000 | – | 20,508 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |